IP Library Patent Application 11989068
Patent Application
App. No. 11/989,068

novel use of activators and stimulators of soluble guanylate cyclase for the prevention or treatment of renal disorders

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/989,068
Abstract

The present invention relates generally to a method for the treatment of renal failure or renal hypertension and, more particularly, for improving the recovery from acute renal failure or renal hypertension by treatment with activators of soluble guanylate cyclase or stimulators of guanylate cyclase.

Claims (6)

1 . A method for prophylaxis and/or treatment of renal failure or renal hypertension comprising administering an effective amount of a compound selected from compounds of formulas (I) to (VI)

or a salt, hydrate, or hydrate of a salt thereof.

2 . The method according to claim 1 for improving the recovery from acute renal failure or renal hypertension.

3 . The method according to claim 1 , wherein the medicament is for oral use compound is administered orally.

4 . The method according to claim 1 , wherein the compound is administered prophylactically.

5 . A pharmaceutical composition for the treatment of renal failure or renal hypertension, comprising at least one compound of the formulas (I) to (VI), as defined in claim 1 .

Assignments (2)
MERGER Recorded Feb 18, 2011
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 025837/0666 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2009
From: KRAHN, THOMAS; STASCH, JOHANNES-PETER; WEIMANN, GERRIT; THIELEMANN, WOLFGANG; RINKE, MATTHIAS
To: BAYER HEALTHCARE AG
Reel/Frame 023415/0523 →